Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias
NCT07342413Phase 4Not yet recruiting
- Sponsor
- Cosmetic Laser Dermatology
- Start
- Feb 2026
- Primary completion
- May 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of epinephrine in telangiectasia, sponsored by Cosmetic Laser Dermatology. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
epinephrine
03
Conditions
telangiectasia
Beyond the preview
Go deeper on NCT07342413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07342413.